Henry Schein, Inc. (HSIC)
NASDAQ: HSIC · Real-Time Price · USD
77.24
-0.81 (-1.04%)
Feb 21, 2025, 4:00 PM EST - Market closed
Henry Schein Revenue
Henry Schein had revenue of $3.17B in the quarter ending September 28, 2024, with 0.38% growth. This brings the company's revenue in the last twelve months to $12.50B, down -1.53% year-over-year. In the year 2023, Henry Schein had annual revenue of $12.34B, down -2.44%.
Revenue (ttm)
$12.50B
Revenue Growth
-1.53%
P/S Ratio
0.79
Revenue / Employee
$499,960
Employees
25,000
Market Cap
9.63B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 30, 2023 | 12.34B | -308.00M | -2.44% |
Dec 31, 2022 | 12.65B | 246.00M | 1.98% |
Dec 25, 2021 | 12.40B | 2.28B | 22.55% |
Dec 26, 2020 | 10.12B | 133.20M | 1.33% |
Dec 28, 2019 | 9.99B | 568.20M | 6.03% |
Dec 29, 2018 | Pro | Pro | Pro |
Dec 30, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 26, 2015 | Pro | Pro | Pro |
Dec 27, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
HSIC News
- 10 days ago - Henry Schein Chairman and CEO Stanley M. Bergman Receives National Association of Wholesaler-Distributors Dirk Van Dongen Lifetime Achievement Award - Business Wire
- 12 days ago - Give Kids A Smile Program Celebrates 23rd Year of Providing Free Oral Health Care Services to Underserved Children - Business Wire
- 21 days ago - Japan In The Spotlight; Blockchain In AI's Shadow - Seeking Alpha
- 24 days ago - Henry Schein Announces Strategic Investment by KKR, Board Changes and Provides Preliminary Unaudited Financial Results and 2025 Financial Guidance - Business Wire
- 24 days ago - KKR builds stake in Henry Schein, reaches deal for board seats, WSJ reports - Reuters
- 4 weeks ago - Henry Schein to Webcast Fourth Quarter and Full-Year 2024 Conference Call on Tuesday, February 25, 2025, at 8:00 a.m. ET - Business Wire
- 4 weeks ago - Exclusive: Activist Ananym plans to launch proxy fight at Henry Schein, sources say - Reuters
- 5 weeks ago - Provident Healthcare Partners Advises Acentus in its Acquisition by Henry Schein - PRNewsWire